Breast Cancer News and Research

Latest Breast Cancer News and Research

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.

17 Mar 2015

Researchers find that exercise may slow tumor growth, improve chemotherapy

One way many cancers grow resistant to treatment is by generating a web of blood vessels that are so jumbled they fail to provide adequate oxygen to the tumor. With oxygen starvation, the tumor gains a sort of cloaking device that protects it from the toxic effects of chemotherapy drugs and radiation, which are designed to seek out well-oxygenated tissue.

17 Mar 2015

UF Health Cancer Center - Orlando Health recognized as one of America's Best Breast Centers

UF Health Cancer Center - Orlando Health earns the 2015 Women's Choice Award as one of America's Best Breast Centers, acknowledging its dedication to providing exceptional patient care and treatment.

17 Mar 2015

New research initiative seeks to speed up implementation of health care policy for women veterans

As more women veterans seek health care in the Veterans Administration system, effective approaches are needed to ensure that their unique needs are recognized and met. A special April supplement to Medical Care collects new studies from an ongoing research initiative to inform health care policy for women veterans.

17 Mar 2015

TSRI scientists confirm ribosome assembly as new target for anti-cancer drugs

Ribosomes, ancient molecular machines that produce proteins in cells, are required for cell growth in all organisms, accomplishing strikingly complex tasks with apparent ease. But defects in the assembly process and its regulation can lead to serious biological problems, including cancer.

17 Mar 2015

Medical experts aim to offer lifesaving treatments to eliminate preventable deaths from AKI by 2025

Preventable deaths caused by acute kidney injury (AKI) could be nearly eliminated in just 10 years, according to leading medical experts. This often forgotten condition - which affects around 13 million people every year and contributes to 1.7 million deaths annually - is preventable and can be treated for as little as $US150 per patient.

17 Mar 2015

Vaxil Bio's ImMucin receives EMA orphan drug designation for treatment of Multiple Myeloma

Vaxil Bio, a leading developer of immunotherapeutic products to treat cancer and infectious diseases, reports today that its lead drug candidate, ImMucin has received orphan drug designation from the European Medicines Agency of the European Commission for the treatment of Multiple Myeloma (MM), a blood cancer.

16 Mar 2015

Study sheds light on cell migration mechanisms involved in wound-healing process

Researchers at the University of Arizona have discovered what causes and regulates collective cell migration, one of the most universal but least understood biological processes in all living organisms.

16 Mar 2015

Low mammographic breast density worsens prognosis of breast cancer, shows study

Very low mammographic breast density worsens the prognosis of breast cancer, according to a recent study from the University of Eastern Finland.

13 Mar 2015

AdMeTech Foundation announces launch of statewide prostate cancer awareness program

AdMeTech Foundation today announced the launch of a statewide prostate cancer education and awareness campaign supported by the Massachusetts Department of Public Health.

12 Mar 2015

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).

12 Mar 2015

Wistar awarded grant to create Jayne Koskinas Ted Giovanis Breast Cancer Research Consortium

The Jayne Koskinas Ted Giovanis Foundation awarded The Wistar Institute a $1.1 million grant to create The Jayne Koskinas Ted Giovanis Breast Cancer Research Consortium at The Wistar Institute. The Consortium will support the highly synergistic, multidisciplinary research projects of three Wistar scientists dedicated to advancing breast cancer research.

12 Mar 2015

Sanford-Burnham researchers discover control mechanism for glutamine uptake in breast cancer cells

Researchers at Sanford-Burnham Medical Research Institute have discovered a mechanism that explains why some breast cancer tumors respond to specific chemotherapies and others do not. The findings highlight the level of glutamine, an essential nutrient for cancer development, as a determinant of breast cancer response to select anticancer therapies, and identify a marker associated with glutamine uptake, for potential prognosis and stratification of breast cancer therapy.

11 Mar 2015

New patient-centered mobile app launched for breast cancer patients

Apple and Sage Bionetworks, together with UCLA cancer research pioneer and collaborator Dr. Patricia Ganz, today announced the launch of Share the Journey: Mind, Body and Wellness after Breast Cancer, a patient-centered mobile app that empowers women to be partners in the research process by tracking their symptoms and successes.

10 Mar 2015

Hormone therapy does not safeguard post-menopausal women against cardiovascular disease

New evidence published today in the Cochrane Library shows that hormone replacement therapy does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke.

10 Mar 2015

Whole genome sequencing may help identify disease risks

Using a small amount of blood or saliva, a technology called whole genome sequencing makes that possible - and more than half of parents said they'd not only be interested in the technology for themselves but for their children too, a new nationally-representative University of Michigan study shows.

10 Mar 2015

Study: A family history of prostate cancer may increase women's risk of developing breast cancer

Having a family history of prostate cancer among first-degree relatives may increase a woman's risk of developing breast cancer. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

10 Mar 2015

New study finds that fetus exposed to tobacco smoke faces diabetes risk in adulthood

A fetus exposed to tobacco smoke may be at increased risk for diabetes in adulthood, a new study of adult daughters finds.

9 Mar 2015

New review finds no link between menopausal hormone therapy and mortality risk

Menopausal hormone therapy (HT) does not have a significant effect on death, according to a new review of the medical literature published over the past three decades.

9 Mar 2015

Oncologists welcome gene expression profiling tests for women with early-stage breast cancer but have concerns

Oncologists welcome gene expression profiling tests as an added tool in deciding whether women with early-stage breast cancer should have chemotherapy, a new study has found. But they have significant reservations about the cost of the test and whether it is being overused and used for the right patients.

9 Mar 2015

Breast Cancer News and Research

Latest Breast Cancer News and Research

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Researchers find that exercise may slow tumor growth, improve chemotherapy

UF Health Cancer Center - Orlando Health recognized as one of America's Best Breast Centers

New research initiative seeks to speed up implementation of health care policy for women veterans

TSRI scientists confirm ribosome assembly as new target for anti-cancer drugs

Medical experts aim to offer lifesaving treatments to eliminate preventable deaths from AKI by 2025

Vaxil Bio's ImMucin receives EMA orphan drug designation for treatment of Multiple Myeloma

Study sheds light on cell migration mechanisms involved in wound-healing process

Low mammographic breast density worsens prognosis of breast cancer, shows study

AdMeTech Foundation announces launch of statewide prostate cancer awareness program

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Wistar awarded grant to create Jayne Koskinas Ted Giovanis Breast Cancer Research Consortium

Sanford-Burnham researchers discover control mechanism for glutamine uptake in breast cancer cells

New patient-centered mobile app launched for breast cancer patients

Hormone therapy does not safeguard post-menopausal women against cardiovascular disease

Whole genome sequencing may help identify disease risks

Study: A family history of prostate cancer may increase women's risk of developing breast cancer

New study finds that fetus exposed to tobacco smoke faces diabetes risk in adulthood

New review finds no link between menopausal hormone therapy and mortality risk

Oncologists welcome gene expression profiling tests for women with early-stage breast cancer but have concerns

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Breast Cancer News and Research

Latest Breast Cancer News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in